Tactic Pharma LLC
Monopar Therapeutics Inc. · 10% Owner
Tactic Pharma LLC is listed in filings as 10% Owner at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Sep 26, 2025, including sale activity. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Apr 4, 2025 to Sep 26, 2025. Reported amounts are shown as $1.2M to $35.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M33.3k shares | SellApr 2, 2025 | $35.00 | $106.91 |